Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Apiam wins $700k grant to build first viral vaccine manufacturing facility for animals
    • News

    Apiam wins $700k grant to build first viral vaccine manufacturing facility for animals

    As the world emerges from the pandemic which has emphasised the critical importance of vaccination, Apiam Animal Health (ASX: AHX) has identified an opportunity to position Australia as leaders in autogenous vaccine manufacturing through the development of a state-of-the-art viral vaccine laboratory in Bendigo, Victoria.  Plans to develop the vaccine lab have been announced, supported

    Read More
    Public
  • Cycliq extends RL bike accessories into Fitness Metaverse with NFTs collectibles
    • News

    Cycliq extends RL bike accessories into Fitness Metaverse with NFTs collectibles

    As more ASX-listed companies identify the unique revenue opportunity to generate something out of nothing, bike accessories company Cycliq (ASX: CYQ) is joining the party with plans to mint NFT collectibles via a partnership with digital health company OliveX (NSX: OLX).  Known primarily for their safety equipment designed for cyclists such as cameras and lights,

    Read More
    Public
  • Gratifii’s customer loyalty tech reaches over 800 restaurants globally
    • News

    Gratifii’s customer loyalty tech reaches over 800 restaurants globally

    Since emerging from lockdown and COVID restrictions, the world has been busy catching up with friends and filling social calendars with coffees, dinners and drinks.  Full social calendars have meant full venues, with vendors breathing a collective sigh of relief now that things are pretty much back to normal. Enterprise loyalty and rewards business Gratifii

    Read More
    Public
  • Halo Technologies IPO: Some Thoughts On Risk
    • Opinion

    Halo Technologies IPO: Some Thoughts On Risk

    I recently reviewed the Halo Technologies IPO (ASX:HAL) prospectuses for its planned listing on the ASX in April 2022. There are several key issues that I’m concerned may deliver suboptimal outcomes for investors. The Setup Halo Technologies provides “online global equities research and trade execution software solution that brings sophisticated institutional-grade analytical frameworks and market insights to everyday

    Read More
    Public
  • Nyrada drug offers potential world first oral treatment for concussion
    • News

    Nyrada drug offers potential world first oral treatment for concussion

    Rummage through any garage and chances are you’ll find a can of WD40. The name arose after 39 failed attempts at creating the trademark degreaser. You know what they say, 40th time’s a charm.  In the pharmaceutical arena, failures, tweaks and fine-tuning are par for the course. Preclinical stage drug development company Nyrada (ASX: NYR)

    Read More
    Public
  • HR transformations through pandemic lead ELMO to launch Hybrid Work and Wellbeing modules
    • News

    HR transformations through pandemic lead ELMO to launch Hybrid Work and Wellbeing modules

    If there’s one division across all businesses that has undergone the largest operational changes, it’s probably human resources, which has had to deal with productivity, absenteeism, working from home and travel restrictions. Having identified how businesses can best manage these challenges, HR tech company ELMO Software (ASX: ELO) has launched new modules for its platform

    Read More
    Public
  • «
  • ‹
  • 394
  • 395
  • 396
  • 397
  • 398
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.